| Literature DB >> 33801094 |
Sadiye Aras1,2, Niamul Kabir1, Sabrina Wadood1, Jyothi George1,2, Shahid Chowdhury1, Aliyar Cyrus Fouladkhah1,3.
Abstract
The inactivation of bacterial endospores continues to be the main curtailment for further adoption of high-pressure processing in intrastate, interstate, and global food commerce. The current study investigated the effects of elevated hydrostatic pressure for the inactivation of endospore suspension of three indicator spore-forming bacteria of concern to the food industry. Additionally, the effects of four bacteriocin/bactericidal compounds were studied for augmenting the decontamination efficacy of the treatment. Elevated hydrostatic pressure at 650 MPa and at 50 °C was applied for 0 min (untreated control) and for 3, 7, and 11 min with and without 50K IU of nisin, 224 mg/L lysozyme, 1% lactic acid, and 1% CitricidalTM. The results were statistically analyzed using Tukey- and Dunnett's-adjusted ANOVA. Under the condition of our experiments, we observed that a well-designed pressure treatment synergized with mild heat and bacteriocin/bactericidal compounds could reduce up to >4 logs CFU/mL (i.e., >99.99%) of bacterial endospores. Additions of nisin and lysozyme were able, to a great extent, to augment (p < 0.05) the decontamination efficacy of pressure-based treatments against Bacillus amyloliquefaciens and Bacillus atrophaeus, while exhibiting no added benefit (p ≥ 0.05) for reducing endospores of Geobacillus stearothermophilus. The addition of lactic acid, however, was efficacious for augmenting the pressure-based reduction of bacterial endospores of the three microorganisms.Entities:
Keywords: bacterial endospores; bioactive compounds; high-pressure processing
Year: 2021 PMID: 33801094 PMCID: PMC8004097 DOI: 10.3390/microorganisms9030653
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Inactivation of Bacillus amyloliquefaciens (AMY), Geobacillus stearothermophilus (GEO), and Bacillus atrophaeus (ATR) treated with the elevated hydrostatic pressure of 650 MPa at 50 °C in carrot juice. (A) Treatments without any added antimicrobial. (B) Treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 50K IU (w/v) nisin. (C) Treated with the elevated hydrostatic pressure of 650 MPa at 50 °C with 224 mg/L (w/v) lysozyme. For each panel of the figure and each bacterium separately, columns followed by different uppercase letters are statistically (p < 0.05) different from each other (Tukey-adjusted ANOVA). Columns followed by * sign are statistically (p < 0.05) different from the control (Dunnett’s-adjusted ANOVA).
Figure 2Inactivation of Bacillus amyloliquefaciens (AMY), Geobacillus stearothermophilus (GEO), and Bacillus atrophaeus (ATR) treated with the elevated hydrostatic pressure of 650 MPa at 50 °C in distilled water. (A) Treatments without any added antimicrobial. (B) Treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 1% (v/v) lactic acid. (C) Treated with the elevated hydrostatic pressure of 650 MPa at 50 °C with 1% (v/v) CitricidalTM. For each panel of the figure and each bacterium separately, columns followed by different uppercase letters are statistically (p < 0.05) different from each other (Tukey-adjusted ANOVA). Columns followed by * sign are statistically (p < 0.05) different from the control (Dunnett’s-adjusted ANOVA).
Inactivation indices for B. amyloliquefaciens, G. stearothermophilus, and B. atrophaeus.
| Pathogen | Treatement a | Medium | D-Value b | Kmax c | R2 | Std Error |
|---|---|---|---|---|---|---|
|
| HPP | Carrot Juice | 3.45 | 0.67 | 0.57 | 0.15 |
| HPP + Nisin | Carrot Juice | 3.34 | 0.83 | 0.48 | 0.23 | |
| HPP + Lysozyme | Carrot Juice | 2.85 | 1.01 | 0.62 | 0.21 | |
|
| HPP | Carrot Juice | - d | - | - | - |
| HPP + Nisin | Carrot Juice | 8.18 | 0.28 | 0.11 | 0.16 | |
| HPP + Lysozyme | Carrot Juice | 41.84 | 0.51 | 0.36 | 0.31 | |
|
| HPP | Carrot Juice | 2.82 | 0.98 | 0.62 | 0.21 |
| HPP + Nisin | Carrot Juice | 3.61 | 0.56 | 0.26 | 0.40 | |
| HPP + Lysozyme | Carrot Juice | 3.06 | 0.93 | 0.50 | 0.29 | |
|
| HPP | Distilled Water | 3.32 | 0.69 | 0.81 | 0.25 |
| HPP + Lactic Acid | Distilled Water | 4.11 | 0.56 | 0.12 | 0.57 | |
| HPP + CitricidalTM | Distilled Water | 5.07 | 0.45 | 0.48 | 0.12 | |
|
| HPP | Distilled Water | 131.58 | 0.02 | <0.1 | 0.21 |
| HPP + Lactic Acid | Distilled Water | 14.33 | 0.03 | <0.1 | 0.20 | |
| HPP + CitricidalTM | Distilled Water | 24.33 | 0.04 | <0.1 | 0.12 | |
|
| HPP | Distilled Water | 7.88 | 0.29 | 0.21 | 0.13 |
| HPP + Lactic Acid | Distilled Water | 4.39 | 0.52 | 0.57 | 0.11 | |
| HPP + CitricidalTM | Distilled Water | 5.79 | 0.40 | 0.48 | 0.10 |
a HPP= treated with elevated hydrostatic pressure of 650 MPa at 50 °C, without any antimicrobial. HPP + Nisin = treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 50K IU (w/v) nisin. HPP + Lysozyme = treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 224 mg/L (w/v) lysozyme. HPP + Lactic Acid = treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 1% (v/v) lactic acid. HPP + CitricidalTM = treated with elevated hydrostatic pressure of 650 MPa at 50 °C with 1% (v/v) CitricidalTM. b D-value (min) was calculated and determined as the reciprocal of the positive slope of the best-fitted model (goodness-of-fit indicator of R2 values, α = 0.05), resulting from plotting of endospore counts (log CFU/mL) as affected by treatments. The counts were recorded from non-selective medium, supplemented with 0.6% yeast extract for recovery of heat, pressure, and antimicrobial injured cells. c Kmax values (1/min) are selected using the GInaFiT software. Kmax values indicate the expressions of number of log cycles of reduction in 1/min unit. d No endospore reduction was observed; thus, the inactivation index could not be calculated.